CD103 has been associated with cytotoxicity of CD8+ T cells in several human pathologies, including graft-versus-host disease (GVHD) (9), allogeneic transplant rejection (10–12), autoimmune diseases (13, 14), and cancer (6, 15). This evidence concerns the gene CD8A and graft versus host disease.